ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | 0.0% | 18,406 | +39.0% | 0.00% | – |
| Q2 2023 | $47 | +4.4% | 13,239 | -35.9% | 0.00% | – |
| Q1 2023 | $45 | -90.6% | 20,649 | -48.1% | 0.00% | – |
| Q4 2022 | $478 | -99.7% | 39,778 | +84.6% | 0.00% | – |
| Q3 2022 | $140,000 | +55.6% | 21,543 | +8.7% | 0.00% | – |
| Q2 2022 | $90,000 | -60.4% | 19,819 | -24.7% | 0.00% | – |
| Q1 2022 | $227,000 | -85.5% | 26,329 | -76.0% | 0.00% | – |
| Q4 2021 | $1,566,000 | +128.6% | 109,764 | +252.5% | 0.00% | – |
| Q3 2021 | $685,000 | +40.4% | 31,142 | -14.6% | 0.00% | – |
| Q2 2021 | $488,000 | +134.6% | 36,481 | +78.1% | 0.00% | – |
| Q1 2021 | $208,000 | +1200.0% | 20,483 | +435.8% | 0.00% | – |
| Q4 2020 | $16,000 | +60.0% | 3,823 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -23.1% | 3,823 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +8.3% | 3,823 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -40.0% | 3,823 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | -84.7% | 3,823 | -90.7% | 0.00% | – |
| Q3 2019 | $131,000 | -11.5% | 41,198 | +0.0% | 0.00% | – |
| Q2 2019 | $148,000 | -1.3% | 41,186 | 0.0% | 0.00% | – |
| Q1 2019 | $150,000 | +21.0% | 41,186 | 0.0% | 0.00% | – |
| Q4 2018 | $124,000 | -38.3% | 41,186 | 0.0% | 0.00% | – |
| Q3 2018 | $201,000 | -34.3% | 41,186 | 0.0% | 0.00% | – |
| Q2 2018 | $306,000 | +14.2% | 41,186 | 0.0% | 0.00% | – |
| Q1 2018 | $268,000 | -27.8% | 41,186 | 0.0% | 0.00% | – |
| Q4 2017 | $371,000 | -9.3% | 41,186 | 0.0% | 0.00% | – |
| Q3 2017 | $409,000 | +75.5% | 41,186 | +37.6% | 0.00% | – |
| Q2 2017 | $233,000 | +26.6% | 29,925 | 0.0% | 0.00% | – |
| Q1 2017 | $184,000 | +0.5% | 29,925 | 0.0% | 0.00% | – |
| Q4 2016 | $183,000 | -15.7% | 29,925 | 0.0% | 0.00% | – |
| Q3 2016 | $217,000 | -13.2% | 29,925 | 0.0% | 0.00% | – |
| Q2 2016 | $250,000 | +38.9% | 29,925 | 0.0% | 0.00% | – |
| Q1 2016 | $180,000 | -24.7% | 29,925 | 0.0% | 0.00% | – |
| Q4 2015 | $239,000 | +97.5% | 29,925 | +172.3% | 0.00% | – |
| Q1 2014 | $121,000 | – | 10,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |